This segment explores the treatment journey of a 55-year-old mother and high school teacher with ALK-positive NSCLC and brain metastases, focusing on her experience with lorlatinib therapy.
This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of patients with R/R MM as seen in clinical practice. The hypothetical case was co-developed by staff Medical Writers with Cancer Network/ONN.